Tyra Biosciences (TYRA) Treasury Shares (2020 - 2026)

Tyra Biosciences' (TYRA) quarterly Treasury Shares came in at $6.2 million in Q2 2021, little changed on a QoQ basis from $6.2 million in Q1 2021.

Tyra Biosciences (TYRA) Treasury Shares (2020 - 2026) Analysis & Trends

Tyra Biosciences (TYRA) has 2 years of Treasury Shares data on file, last reported at $6.2 million in Q2 2021.

Quarterly Treasury Shares changed N/A year-over-year to $6.2 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $6.2 million (changed N/A YoY) and the FY2020 annual result came in at $3.4 million, changed N/A from the prior year.
Treasury Shares steadied at $6.2 million in Q2 2021, from $6.2 million in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $6.2 million in Q1 2021 to a low of $3.4 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Tyra Biosciences	1.51 Bn	1.51 Bn	-	455,750.00

Download Data